Company Overview
    Strategy
    Technology and IP
    Management
    Board
    Scientific Advisors
    History
    Collaborations and Partners
    Publications
 
 
Scientific Advisory Board

Dr Simon West - Chairman

Professor Angelo Azzi

Professor Ishwarlal Jialal

Professor John Mills

 

 
Scientific Advisors

 

Dr William Hsu

William C. Hsu, M.D., is a diabetologist, a clinical investigator, an assistant professor of medicine at Harvard Medical School, the director of the Asian Clinic and the Co-Director for the Asian American Diabetes Initiative at Joslin Diabetes Center, Harvard Medical School, in Boston. His research interests focus on developing and applying novel medical technologies for the treatment of diabetes.

 

Dr. Hsu has worked with a number of medical technology companies in the past, bringing clinical insight into product design, development and services. In addition, his research interests extend to understanding the causes of diabetes in Asian Americans. Dr. Hsu received his medical degree from Mount Sinai School of Medicine in New York City, and completed his residence training in internal medicine at Yale New Haven Hospital. He completed his clinical training in endocrinology and metabolism at Beth Israel Deaconess Medical Center and Joslin Diabetes Center, Harvard Medical School. His undergraduate degree is from Cornell University. He has received teaching awards from Yale University School of Medicine and Harvard Medical School. 

 

 

Professor Thomas Rades

Professor Rades is an international authority on drug formulation, he is the author of over 120 internationally peer reviewed journal articles and has received more than 50 grants equating to over $4 million dollars.  

Professor Rades currently holds the position of Chair in Pharmaceutical Sciences, School of Pharmacy, University of Otago. He is a founding member of the European Association of Pharma Biotechnology and a member of the Australasian Pharmaceutical Science Association, International Association for Pharmaceutical Technology, Controlled Release Society, German Pharmaceutical Society and Microscopy New Zealand.

 

 

Dr Simon West

Dr West is one of Australia's leading inventors, with a strong background in industrial chemistry and inventions covering processes in mineral extraction, plastics recycling and production, food technology and natural health care products.

With a 30 year career as an inventor of processes involving physical sciences, Dr  West has had broad experience in the development of original solutions and the technical management of the resulting intellectual property for public companies. Dr West worked for 17 years with Kraft Foods Ltd on projects such as the modification of curd, 'magnetic carbon', automation of jar arrangement and a calcium ion sensor transistor.

Dr West worked on filter aid regeneration and invented, developed and directed the beta carotene process that is now the basis for the commercial success of Betatene Ltd. Dr West invented the zinc tailings recovery process that was used as the basis for the public listing of Denehurst Ltd and was involved as Joint Managing Director in the implementation of that technology. He also invented the crumbing of PET forming part of the Renew process and was involved in building a pilot plant that was used as the basis for 'Innovations in the PET' which is now owned by Petrecycle Ltd.

Dr West holds a Dip App Chem and BSc degree with a double major in chemistry and a DApp Sci (Honorary).

 

 

Professor Angelo Azzi

Professor Angelo Azzi is an international authority on atherosclerosis and is the author of numerous peer-reviewed articles in scientific journals. He has authored more than 400 articles and been an invited speaker to more than 200 international meetings.

Professor Azzi is currently an Honorary Professor at both the University of Bern (Switzerland) and Tufts University in Boston.

 

 

Professor Ishwarlal Jialal

Professor Ishwarlal Jialal, a doctor of medicine and a specialist in human nutrition, is placed in the top three leaders in the area of research when it comes to vitamin E, cardiovascular disease and diabetes. He is based at the UCD Medical Centre at the University of California (Davis) in Sacramento.

Professor Jialal has been published in more than 200 scientifically reviewed publications and has received more than 70 grants, many involving millions of dollars from the National Institute of Health in the US. He sits on many editorial boards including the American Journal of Clinical Nutrition.

 

 

Professor John Mills

Professor Mills holds professorial appointments at Monash University and RMIT, and is a consulting physician at the Alfred and Austin hospitals in Melbourne. He was the Director of the Macfarlane Burnet Institute for Medical Research for 10 years, Australia's premier communicable disease and public health research institute. 

He is also the Executive Chairman of Swedish company, Cavidi AB, an Executive Director of TissuPath Pty Ltd, a non-executive director of GBS Venture Partners Pty Ltd (Australia's largest biotechnology venture capital company), and a non-executive director of the Prostate Cancer Foundation of Australia and Chair of the PCFA Research Committee. He has previously been a non-executive director and Chairman of AMRAD Corporation Ltd and Managing Director of Narhex Life Sciences Ltd (ASX: NLS).

He has published over 200 scientific articles and has served as a consultant to industry and governments, the World Health Organisation and the United Nations.

Professor Mills is a member of the Company’s Audit, Compliance and Corporate Governance Committee.

 
  Home About Us Pharmaceuticals Nutraceuticals Investors News Contact Us Privacy & Disclaimer Site Map
 

Copyright 2005 Phosphagenics Limited

Web Site Design & Business Hosting by Simple I.D.Simple I.D. website design & business hosting Melbourne